1
TÍTULO: SB5 and reference adalimumab show cross-immunogenicity in patients with inflammatory bowel disease or rheumatoid arthritis  Full Text
AUTORES: Goncalves, J; Myung, G; Hong, E; Park, M; Jeong, D; Ghil, J;
PUBLICAÇÃO: 2019, FONTE: JOURNAL OF CROHNS & COLITIS, VOLUME: 13
INDEXADO EM: WOS